IVF Reads / Dealing with Unexplained Infertility

Dealing with Unexplained Infertility

M
Written by MayaPublished Updated
Is Natural Conception Possible After a Failed IVF?
AI summary

Unexplained infertility is diagnosed when a couple has not conceived after 12 months of regular unprotected sex and the standard tests are normal: a semen analysis against WHO reference values, confirmed ovulation, open fallopian tubes and a normal uterus on ultrasound. ESHRE's 2023 guideline puts it at about 30% of infertile couples. NICE's 2026 guideline (NG257) advises trying for a total of 2 years before treatment, says not to use fertility tablets on their own, and then offers IVF, with up to 4 cycles of gonadotrophin-stimulated IUI as an alternative to consider first.

  • ESHRE 2023: about 30% of infertile couples are diagnosed with unexplained infertility; the share depends on how thorough the work-up was.
  • NICE NG257 (2026): try to conceive for a total of 2 years before treatment; do not offer ovarian stimulation tablets as a stand-alone treatment.
  • TUI trial (Lancet 2018, 201 women with a poor natural prognosis): live birth 31% after 3 cycles of stimulated IUI versus 9% with expectant management.
  • IPD meta-analysis (Hum Reprod Update 2024, 908 women): cumulative live birth 50.3% with IVF versus 43.2% with stimulated IUI, not a significant difference.
  • Clomifene alone (BMJ 2008, 580 women over 6 months): 14% live birth versus 17% with no treatment.
  • HFEA 2024 UK data: IVF birth rate per embryo transferred 38% at ages 18-34 versus 8% at 43-44, which is why age usually decides how long to wait.

What does unexplained infertility mean?

It means that after at least a year of trying, the standard tests on both partners have come back normal: sperm, ovulation, fallopian tubes and the womb. It does not mean nothing is wrong, and it does not mean you cannot conceive — it means the usual tests have not found the reason, and many couples in this group still become pregnant, with or without treatment.

It is common. The European Society of Human Reproduction and Embryology (ESHRE) puts it at about 3 in 10 infertile couples, and notes that the proportion depends on how thorough the testing was: the fewer tests done, the more couples end up with this label.

Being told "everything is normal" when you have been trying for a year or more can feel less like good news and more like being left without a plan. The rest of this page is that plan: what should have been checked, what the odds are, and what the treatment options actually achieve.

Infertile couples diagnosed with unexplained infertilityAbout 30%The share rises when the work-up is limited and falls when more causes are looked for, so it is an estimate, not a fixed rate.ESHRE evidence-based guideline: unexplained infertility, Human Reproduction 2023

Which tests must be normal before the label applies?

The label is only as good as the work-up behind it. ESHRE and NICE agree on a short list, and if any of these was skipped, the diagnosis is premature:

  • Semen analysis judged against the WHO 2021 reference values, and repeated after about 3 months if the first result is low. See how to prepare for a semen analysis.
  • Ovulation. Regular cycles of 24 to 38 days usually mean ovulation is happening. NICE also offers a mid-luteal progesterone blood test to confirm it.
  • Open fallopian tubes, usually by HSG or a contrast ultrasound (HyCoSy). See what an HSG shows and cannot show.
  • A normal uterus on ultrasound. ESHRE says no further evaluation is needed if the scan of the cavity is normal.
  • Medical, reproductive and sexual history from both partners, including how often you have sex.

ESHRE's definition also limits the diagnosis to women aged 40 or under. Above that, age itself is treated as a likely cause.

Several tests are often added and usually do not change anything. ESHRE recommends against routine laparoscopy, sperm DNA fragmentation testing when the semen analysis is normal, thrombophilia screening, thyroid antibody testing, vitamin D testing and genetic testing in unexplained infertility. NICE advises against hysteroscopy unless a problem in the womb is suspected, and against using AMH to predict natural conception. Our infertility work-up page lists what a standard assessment covers.

What are the chances of conceiving without treatment?

Better than most couples expect, but they fall with age and with every extra year of trying. In the general population, NICE says over 80% of couples with a woman under 40 conceive within a year, and about half of the rest do so in the second year.

Couples with unexplained infertility start from a lower point, and their chances vary widely. The no-treatment groups in three randomised trials show the range:

  • Couples trying for over two years, in Scotland: 17% had a baby in 6 months without treatment (BMJ 2008).
  • Couples with an intermediate prognosis, in the Netherlands: 27% had an ongoing pregnancy in 6 months without treatment (Lancet 2006).
  • Couples with a poor prognosis, in New Zealand: 9% had a baby over 3 cycles without treatment (Lancet 2018).

So the number that matters is not the average but your own prognosis. ESHRE advises basing the decision to start treatment on it, and names the factors that drive it: the woman's age, how long you have been trying, and whether either of you has had a pregnancy before. NICE's advice is to keep trying for a total of 2 years before treatment. Our fertility timeline sets out how those years are usually counted.

Live birth in 6 months with no treatment, couples trying for over 2 years17%32 of 193 couples randomised to expectant management. Clomifene tablets did no better (14%); unstimulated IUI gave 23%, not a significant difference.Bhattacharya S et al, BMJ 2008;337:a716 (580 couples, Scotland)

Do fertility tablets help on their own?

No. You may be offered clomiphene or letrozole tablets by themselves for unexplained infertility, but NICE's 2026 guideline says not to offer ovarian stimulation as a stand-alone treatment, because its review found it neither effective nor cost-effective.

The trial evidence points the same way. In 580 Scottish couples, 6 months of clomifene gave a live birth rate of 14% against 17% with no treatment. Tablets do have a place when a woman is not ovulating, but that is a different diagnosis.

When does IUI help?

IUI with stimulation (medicine to stimulate the ovaries, then prepared sperm placed in the womb at ovulation) clearly helps couples whose chance of conceiving naturally is low. In the New Zealand TUI trial of 201 women with a poor prognosis, 31% had a baby after three cycles of stimulated IUI, against 9% with expectant management.

For couples with a better prognosis it may add little. A Dutch trial of 253 couples with a 30 to 40% predicted chance of natural pregnancy within a year found no benefit from six months of stimulated IUI: 23% ongoing pregnancy against 27% with expectant management. The 2020 Cochrane review reached the same split — a probable benefit when the natural prognosis is low, uncertainty otherwise.

The main risk is twins or more. NICE now suggests considering up to 4 cycles of IUI stimulated with gonadotrophin injections before IVF; ESHRE asks for low-dose gonadotrophins with adequate monitoring to keep the multiple-pregnancy and ovarian hyperstimulation risk down.

Live birth after 3 cycles, stimulated IUI vs no treatment31% vs 9%Women with unexplained infertility and a poor prognosis for natural conception; 101 and 100 women. Two sets of twins, both in the IUI group.Farquhar CM et al (TUI trial), Lancet 2018;391:441-450

Is IVF better than IUI for unexplained infertility?

Not clearly, on the trials so far. When the original data from four trials (908 women) were pooled and compared over the same time frame, 50.3% had a baby with IVF and 43.2% with stimulated IUI — a difference that was not statistically significant. Twin rates were similar. The authors concluded that both are reasonable options, and that cost and preference should decide.

The two main guidelines read this evidence differently, and it is worth knowing both. ESHRE (2023) recommends stimulated IUI first and says IVF is "probably not recommended" over it. NICE (2026) concluded IVF is the most cost-effective first treatment after two years of trying, with stimulated IUI as an alternative for couples who prefer something less invasive. ESHRE also notes that none of its 40 evidence-based recommendations on unexplained infertility rests on high-quality evidence.

IVF does one thing the tests cannot: it shows whether the eggs and sperm fertilise in the lab. It is also the most expensive and invasive option. An ICMR study of 148 couples at five tertiary hospitals found an average out-of-pocket cost of ₹2,30,668 per IVF cycle in private hospitals and ₹1,10,104 in public ones.

Cumulative live birth, IVF vs stimulated IUI50.3% vs 43.2%Individual data from 4 randomised trials, 908 women, compared over the same follow-up time. Hazard ratio 1.19 (95% CI 0.81 to 1.74): not a significant difference.Lai S et al, Human Reproduction Update 2024;30(2):174-185

Why does age usually decide?

Because waiting costs more time the older you are. NICE's table for the general population shows the drop: 92% of women aged 19 to 26 conceive within a year, against 82% at 35 to 39. NICE refers women aged 36 or over to a specialist straight away rather than asking them to wait.

The same pattern shows in IVF. In UK national data for 2024, the birth rate per embryo transferred was 38% for patients aged 18 to 34 and 8% at 43 to 44. Over 2022 to 2024 the same register showed lower rates for Asian patients aged 18 to 37 (30%) than for White patients (36%), for reasons the regulator says its data do not explain — a reminder that foreign averages are a guide, not a promise.

Put together, the trade-off looks like this. In a younger couple with a short history, waiting longer or trying IUI first is reasonable, because time is not yet the scarce resource. In the late 30s, months spent on IUI that may not work are part of the cost, which is why ESHRE says the decision to use IVF should be individualised by age, duration of infertility, previous treatment and previous pregnancy. In India the ART Act limits IVF and other ART services to women over 21 and under 50, and men over 21 and under 55.

What does not help?

ESHRE's guideline is unusually direct about extras offered to couples with unexplained infertility:

  • Endometrial scratching — "should not be offered", a strong recommendation. See our review of the scratching trials.
  • ICSI instead of standard IVF — not recommended when the sperm is normal.
  • Hysteroscopy to look for hidden problems — not recommended when the scan is normal.
  • Antioxidant supplements, acupuncture and inositol — probably not recommended.

What ESHRE does support is ordinary: a healthy diet and regular exercise, and psychological support for anyone who needs it. It also suggests discussing tubal flushing with an oil-based dye during HSG, a conditional recommendation based on low-quality evidence.

[Unexplained infertility] is inevitably a diagnosis by exclusion, following otherwise ‘standard’ investigations.— ESHRE evidence-based guideline: unexplained infertility (2023)

What should you do next?

  1. Check the work-up is complete: a WHO-standard semen analysis, confirmed ovulation, a tubal test and a uterine scan. If one is missing, the label is premature.
  2. Count how long you have actually been trying, and note the woman's age. Those two numbers drive most of the decision.
  3. Ask the clinic for its estimate of your chance of conceiving naturally over the next 12 months, and how it worked that out.
  4. If treatment is suggested, ask whether it is stimulated IUI or IVF, how many cycles before reassessing, and what each costs in full. Indian law (ART Act 2021, section 21) requires clinics to explain chances of success, cost and risks, including twins.
  5. Decline tablets on their own and add-ons such as scratching unless the clinic can point to evidence for your situation.

Sometimes the right answer is more time, not more treatment — and sometimes, especially later in the 30s, it is moving to IVF without spending a year on steps unlikely to work. A disclosure: IVF Pulse runs fertility clinics in Bangalore that offer IUI and IVF; the evidence above applies to those as much as to anyone else's.

Told your tests are all normal?

Upload your reports. We will check whether the standard work-up is complete and set out what the guidelines suggest at your stage.

Keep reading

12 Sources

  1. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257, published 31 March 2026 (replaces CG156). Rec 1.38.1-1.38.3 (2 years of trying; no stand-alone ovarian stimulation; up to 4 cycles of gonadotrophin-stimulated IUI or IVF), 1.16.5-1.16.8, 1.17.1, 1.18.3, 1.18.13-1.18.16, 1.39.3-1.39.9, and the rationale section for unexplained fertility problems. NICE
  2. NICE NG257, recommendation 1.4.1 and table 1: over 80% of couples conceive within 1 year, about half of the rest in the second year; cumulative pregnancy by age (92% at 19-26, 82% at 35-39 after 1 year). General population, not unexplained infertility. NICE
  3. Guideline Group on Unexplained Infertility; Romualdi D, et al. Evidence-based guideline: unexplained infertility. Hum Reprod 2023;38(10):1881-1890. PMID 37599566. Definition, ~30% prevalence, diagnostic and treatment recommendations. Human Reproduction (ESHRE)
  4. Farquhar CM, et al. Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI). Lancet 2018;391:441-450. PMID 29174128. Live birth 31% vs 9%, RR 3.41 (1.71-6.79). The Lancet
  5. Steures P, et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis. Lancet 2006;368:216-221. PMID 16844491. Ongoing pregnancy 23% vs 27%, RR 0.85 (0.63-1.1). The Lancet
  6. Bhattacharya S, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility. BMJ 2008;337:a716. PMID 18687718. Live birth 17% expectant, 14% clomifene, 23% unstimulated IUI. BMJ
  7. Ayeleke RO, et al. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2020;3:CD001838. PMID 32124980. Stimulated IUI vs expectant management with low prognosis: OR 4.48 (2.00-10.01). Cochrane Database of Systematic Reviews
  8. Lai S, et al. IVF versus IUI with ovarian stimulation for unexplained infertility: a collaborative individual participant data meta-analysis. Hum Reprod Update 2024;30(2):174-185. PMID 38148104. 50.3% vs 43.2%, HR 1.19 (0.81-1.74). Human Reproduction Update
  9. Sunkara SK, et al. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev 2023;9:CD003357. PMID 37753821. IVF may improve live birth over unstimulated IUI; overall evidence quality low. Cochrane Database of Systematic Reviews
  10. Human Fertilisation and Embryology Authority. Fertility treatment 2024: trends and figures (published June 2026). Birth rate per embryo transferred 38% at 18-34, 8% at 43-44; Asian 30% vs White 36% at 18-37 (2022-24). 2024 figures preliminary. HFEA
  11. The Assisted Reproductive Technology (Regulation) Act, 2021 (No. 42 of 2021), Gazette of India. Section 21(c) duty to counsel on chances of success, cost and risks including multiple pregnancy; section 21(g) age limits (women 21-50, men 21-55). Government of India
  12. Patil P, et al. Out-of-pocket expenditure experienced by couples seeking IVF services at tertiary care facilities in India. PLoS One 2026;21(7):e0351080. PMID 42455781 (ICMR-NIRRCH). 148 couples; mean ₹2,30,668 private, ₹1,10,104 public per cycle. PLoS One (ICMR-NIRRCH)

Frequently asked questions

Five questions the sections above do not answer.

Does a miscarriage restart the two-year count?

No. NICE's 2026 guideline says that if a miscarriage or ectopic pregnancy happens during the first year of trying, or during the period of expectant management for unexplained infertility, the timeframe continues rather than starting again.

Should we have a laparoscopy to look for hidden endometriosis?

Not routinely. ESHRE recommends against routine diagnostic laparoscopy for unexplained infertility: it found too little good evidence that skipping it misses anything clinically important in women at low risk of tubal disease, and surgery carries its own risks. NICE offers laparoscopy when there is a reason to suspect a problem, such as a past pelvic infection, ectopic pregnancy or symptoms of endometriosis. If mild endometriosis is found, ESHRE no longer counts the case as unexplained.

Can an AMH test tell us our chance of conceiving naturally?

No. NICE (2026) says AMH should not be used to predict natural conception, and ESHRE (2023) says ovarian reserve testing is not needed for that in women with regular cycles. It is useful for something else: estimating how the ovaries are likely to respond to IVF stimulation.

Is IUI without fertility drugs worth trying?

The evidence is weak. In the Scottish trial, unstimulated IUI gave a 23% live birth rate over 6 months against 17% with no treatment, a difference that was not statistically significant. The 2020 Cochrane review rated the evidence low quality and could not say whether it helps.

Does NICE's two-year rule apply in India?

NICE is a UK guideline and is not binding in India; we have not found an Indian guideline that sets a different timeframe for unexplained infertility. Its reasoning — that many couples conceive in the second year — is not specific to the UK. It also has a built-in age limit: NICE refers women aged 36 or over to a specialist straight away.